Larry Lopez

Larry Lopez, Pharm.D., FCCP, BCPS

Professor Emeritus

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6234
Business Email: lopez@cop.ufl.edu

About Larry Lopez

Dr. Larry Lopez joined the faculty of the University of Florida College of Pharmacy in September, 1979, after completing requirements for his post-baccalaureate Doctor of Pharmacy degree. Before accepting the faculty appointment he had worked as a community pharmacist and a hospital pharmacist for nearly 10 years. He received his high school diploma in 1964 from Jesuit High School in Tampa, Florida and his Bachelor of Science in Pharmacy from the University of Florida College of Pharmacy in 1969. Dr. Lopez retired from the faculty on November 30, 2011, after 32 years of service.

While a member of the faculty Dr. Lopez was responsible for teaching a number of topics related to the pharmacotherapy of both general internal medicine and cardiovascular disorders for the Colleges of Pharmacy and Medicine. He also maintained clinical practices in Internal Medicine and Anticoagulation at Shands at the University of Florida for the last 10 years of his appointment. Dr. Lopez served as Chairman of the Department of Pharmacy Practice from January, 1997 until July, 2002, Associate Chair of the same department from July, 2002, until July, 2011, when he once again assumed the position of Department Chairman until his retirement later that year.

Dr. Lopez’s research revolved primarily around clinical evaluations of new therapeutic modalities for management of hypertension, myocardial ischemia and/or congestive heart failure. He received over 30 grants and contracts for support of his work in these areas and published approximately 130 abstracts, articles, monographs, and chapters on these and other topics as well. Dr. Lopez was recognized for his research accomplishments by being named as a Fellow of the American College of Clinical Pharmacy and the American Society of Hypertension. He was Board Certified as a Pharmacotherapy Specialist in October, 2004.

AFFILIATIONS American College of Clinical Pharmacy North Central Florida Society of Health-System Pharmacists American Heart Association Florida Society of Health-System Pharmacists Board of Pharmaceutical Specialties

Research Profile

Research interests: Rational drug therapy of hypertension, ischemic heart disease, and congestive heart failure. Relationships between pharmacokinetics and pharmacodynamics of agents used for management of hypertension, myocardial ischemia, and congestive heart failure.

Publications

2017
Dispersal of Amblyseius swirskii (Acari: Phytoseiidae) on High-Tunnel Bell Peppers in Presence or Absence of Polyphagotarsonemus latus (Acari: Tarsonemidae).
Journal of insect science (Online). 17(1) [DOI] 10.1093/jisesa/iew095. [PMID] 28025305.
2015
Acute Toxicity and Sublethal Effects of Fenpyroximate to Amblyseius swirskii (Acari: Phytoseiidae).
Journal of economic entomology. 108(3):1047-53 [DOI] 10.1093/jee/tov033. [PMID] 26470228.
2010
Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
The Annals of pharmacotherapy. 44(1):88-96 [DOI] 10.1345/aph.1L289. [PMID] 20040704.
2009
Key articles and guidelines for the prevention of venous thromboembolism.
Pharmacotherapy. 29(4):410-58 [DOI] 10.1592/phco.29.4.410. [PMID] 19323620.
2006
Depressive symptoms in coronary artery disease patients after hypertension treatment.
The Annals of pharmacotherapy. 40(4):597-604 [PMID] 16569807.
View on: PubMed
2006
Increased cardiovascular risk with second-generation antipsychotic agent switches.
Journal of the American Pharmacists Association : JAPhA. 46(4):491-8; quiz 499 [PMID] 16913393.
View on: PubMed
2006
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.
Clinical pharmacology and therapeutics. 79(4):291-302 [PMID] 16580898.
View on: PubMed
2006
The wild ride: cardiology and clinical pharmacy 1967-2005.
The Annals of pharmacotherapy. 40(6):1172-3 [PMID] 16684810.
View on: PubMed
2005
Rosuvastatin: a high-potency HMG-CoA reductase inhibitor.
Journal of the American Pharmacists Association : JAPhA. 45(4):503-13 [PMID] 16128507.
View on: PubMed
2004
Cholesterol: point-of-care testing.
The Annals of pharmacotherapy. 38(7-8):1252-7 [PMID] 15178733.
View on: PubMed
2004
Home blood pressure monitoring: point-of-care testing.
The Annals of pharmacotherapy. 38(5):868-73 [PMID] 15054146.
View on: PubMed
2003
Clinical challenges of bleeding in percutaneous coronary intervention.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 60(14 Suppl 3):S8-14 [PMID] 12908377.
View on: PubMed
2003
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
American heart journal. 145(2):324-9 [PMID] 12595851.
View on: PubMed
2002
Managing hyperlipidemia: current and future roles of HMG-CoA reductase inhibitors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 59(12):1173-9; quiz 1180 [PMID] 12073858.
View on: PubMed
1997
Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Journal of the American College of Cardiology. 30(4):955-61 [PMID] 9316524.
View on: PubMed

Teaching Profile

Courses Taught
2006-2008,2012-2014,2014
PHA5782 Pharmacotherapy 2
2009-2011,2013
PHA5783 Pharmacotherapy 3
2010-2011
PHA5788 Pharmacotherapy 6
2006,2008-2009
PHA5781 Pharmacotherapy 1

Contact Details

Phones:
Business:
(352) 273-6234
Emails:
Business:
lopez@cop.ufl.edu